NantHealth, Inc. (NASDAQ: NH) Stock Competitors & Peer Comparison
See NH's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for NH and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| NH | $1.35 | +0.00% | 0 | -0.12 | -$11.40 | N/A |
| VEEV | $190.25 | -2.63% | 32.1B | 23.70 | $8.33 | N/A |
| GEHC | $62.19 | -1.40% | 28.6B | 13.78 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSGU | $236.33 | +2.07% | 13.9B | 209.28 | $1.11 | N/A |
| BTSG | $71.84 | +1.63% | 13.8B | 56.85 | $1.24 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| TEM | $49.24 | -6.16% | 8.4B | -96.82 | -$0.50 | N/A |
| HQY | $98.56 | +0.91% | 8.3B | 23.10 | $4.28 | N/A |
| HNGE | $83.97 | -3.58% | 6.8B | 45.02 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
NH vs VEEV Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, VEEV has a market cap of 32.1B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while VEEV trades at $190.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas VEEV's P/E ratio is 23.70. In terms of profitability, NH's ROE is +0.35%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, NH is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for NH.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
NH vs GEHC Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, GEHC has a market cap of 28.6B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while GEHC trades at $62.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas GEHC's P/E ratio is 13.78. In terms of profitability, NH's ROE is +0.35%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, NH is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for NH.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
NH vs GEHCV Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas GEHCV's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, NH is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for NH.Check GEHCV's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
NH vs BTSGU Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, BTSGU has a market cap of 13.9B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while BTSGU trades at $236.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas BTSGU's P/E ratio is 209.28. In terms of profitability, NH's ROE is +0.35%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, NH is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for NH.Check BTSGU's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
NH vs BTSG Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, BTSG has a market cap of 13.8B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while BTSG trades at $71.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas BTSG's P/E ratio is 56.85. In terms of profitability, NH's ROE is +0.35%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, NH is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for NH.Check BTSG's competition here
Signify Health, Inc. (NYSE: SGFY)
NH vs SGFY Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SGFY's P/E ratio is 70.91. In terms of profitability, NH's ROE is +0.35%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, NH is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for NH.Check SGFY's competition here
Tempus AI, Inc. (NASDAQ: TEM)
NH vs TEM Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, TEM has a market cap of 8.4B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while TEM trades at $49.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas TEM's P/E ratio is -96.82. In terms of profitability, NH's ROE is +0.35%, compared to TEM's ROE of -0.70%. Regarding short-term risk, NH is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for NH.Check TEM's competition here
HealthEquity, Inc. (NASDAQ: HQY)
NH vs HQY Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while HQY trades at $98.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas HQY's P/E ratio is 23.10. In terms of profitability, NH's ROE is +0.35%, compared to HQY's ROE of +0.11%. Regarding short-term risk, NH is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for NH.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
NH vs HNGE Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while HNGE trades at $83.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas HNGE's P/E ratio is 45.02. In terms of profitability, NH's ROE is +0.35%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, NH is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for NH.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
NH vs RCM Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, RCM has a market cap of 6B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas RCM's P/E ratio is -102.21. In terms of profitability, NH's ROE is +0.35%, compared to RCM's ROE of +0.00%. Regarding short-term risk, NH is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for NH.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
NH vs TXG Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, TXG has a market cap of 5.5B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while TXG trades at $46.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas TXG's P/E ratio is -254.24. In terms of profitability, NH's ROE is +0.35%, compared to TXG's ROE of -0.03%. Regarding short-term risk, NH is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for NH.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
NH vs DOCS Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, DOCS has a market cap of 4.1B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while DOCS trades at $21.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas DOCS's P/E ratio is 14.21. In terms of profitability, NH's ROE is +0.35%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, NH is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for NH.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
NH vs ONEM Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas ONEM's P/E ratio is -7.77. In terms of profitability, NH's ROE is +0.35%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, NH is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for NH.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
NH vs PRVA Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, PRVA has a market cap of 3.3B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while PRVA trades at $26.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas PRVA's P/E ratio is 164.13. In terms of profitability, NH's ROE is +0.35%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, NH is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for NH.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
NH vs PGNY Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while PGNY trades at $31.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas PGNY's P/E ratio is 23.19. In terms of profitability, NH's ROE is +0.35%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, NH is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for NH.Check PGNY's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
NH vs WGSWW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, WGSWW has a market cap of 2.4B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, NH's ROE is +0.35%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, NH is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for NH.Check WGSWW's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
NH vs HTFL Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, HTFL has a market cap of 2.1B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while HTFL trades at $25.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas HTFL's P/E ratio is -12.22. In terms of profitability, NH's ROE is +0.35%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, NH is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for NH.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
NH vs WGS Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, WGS has a market cap of 1.8B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while WGS trades at $60.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas WGS's P/E ratio is 71.35. In terms of profitability, NH's ROE is +0.35%, compared to WGS's ROE of -0.28%. Regarding short-term risk, NH is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for NH.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
NH vs TDOC Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while TDOC trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas TDOC's P/E ratio is -10.72. In terms of profitability, NH's ROE is +0.35%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, NH is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for NH.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
NH vs NXGN Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas NXGN's P/E ratio is -266.00. In terms of profitability, NH's ROE is +0.35%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, NH is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for NH.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
NH vs OMDA Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while OMDA trades at $22.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas OMDA's P/E ratio is 341.29. In terms of profitability, NH's ROE is +0.35%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, NH is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for NH.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
NH vs AGTI Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas AGTI's P/E ratio is -71.79. In terms of profitability, NH's ROE is +0.35%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, NH is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for NH.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
NH vs GDRX Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while GDRX trades at $3.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas GDRX's P/E ratio is 9.52. In terms of profitability, NH's ROE is +0.35%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, NH is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for NH.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
NH vs CERT Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while CERT trades at $6.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas CERT's P/E ratio is 17.79. In terms of profitability, NH's ROE is +0.35%, compared to CERT's ROE of -0.01%. Regarding short-term risk, NH is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for NH.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
NH vs CCLDO Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas CCLDO's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, NH is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for NH.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
NH vs HSTM Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, HSTM has a market cap of 827.7M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while HSTM trades at $27.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas HSTM's P/E ratio is 37.28. In terms of profitability, NH's ROE is +0.35%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, NH is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for NH.Check HSTM's competition here
Evolent Health, Inc. (NYSE: EVH)
NH vs EVH Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, EVH has a market cap of 667M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while EVH trades at $5.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas EVH's P/E ratio is 593.00. In terms of profitability, NH's ROE is +0.35%, compared to EVH's ROE of -0.78%. Regarding short-term risk, NH is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for NH.Check EVH's competition here
Phreesia, Inc. (NYSE: PHR)
NH vs PHR Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, PHR has a market cap of 660.5M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while PHR trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas PHR's P/E ratio is 38.16. In terms of profitability, NH's ROE is +0.35%, compared to PHR's ROE of +0.03%. Regarding short-term risk, NH is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for NH.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
NH vs MPLN-WT Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, NH is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for NH.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
NH vs ACCD Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas ACCD's P/E ratio is -3.08. In terms of profitability, NH's ROE is +0.35%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, NH is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for NH.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
NH vs SHCR Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SHCR's P/E ratio is -3.76. In terms of profitability, NH's ROE is +0.35%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, NH is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for NH.Check SHCR's competition here
Claritev Corporation (NYSE: CTEV)
NH vs CTEV Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, CTEV has a market cap of 514.7M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while CTEV trades at $29.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas CTEV's P/E ratio is -2.32. In terms of profitability, NH's ROE is +0.35%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, NH is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for NH.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
NH vs NRC Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, NRC has a market cap of 482.5M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while NRC trades at $20.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas NRC's P/E ratio is 26.11. In terms of profitability, NH's ROE is +0.35%, compared to NRC's ROE of +0.57%. Regarding short-term risk, NH is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for NH.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
NH vs SOPH Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SOPH trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SOPH's P/E ratio is -11.29. In terms of profitability, NH's ROE is +0.35%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, NH is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for NH.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
NH vs SLGC Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SLGC's P/E ratio is -3.04. In terms of profitability, NH's ROE is +0.35%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, NH is more volatile compared to SLGC. This indicates higher risk in terms of short-term price fluctuations for NH.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
NH vs SLGCW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, NH's ROE is +0.35%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, NH is more volatile compared to SLGCW. This indicates higher risk in terms of short-term price fluctuations for NH.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
NH vs TBRG Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas TBRG's P/E ratio is 9.37. In terms of profitability, NH's ROE is +0.35%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, NH is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for NH.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
NH vs MPLN Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas MPLN's P/E ratio is -0.23. In terms of profitability, NH's ROE is +0.35%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, NH is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for NH.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
NH vs SLP Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SLP has a market cap of 368.3M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SLP's P/E ratio is 20.69. In terms of profitability, NH's ROE is +0.35%, compared to SLP's ROE of +0.06%. Regarding short-term risk, NH is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for NH.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
NH vs TRHC Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas TRHC's P/E ratio is -4.27. In terms of profitability, NH's ROE is +0.35%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, NH is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for NH.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
NH vs SMFR Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SMFR's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, NH is more volatile compared to SMFR. This indicates higher risk in terms of short-term price fluctuations for NH.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
NH vs SPOK Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SPOK has a market cap of 222.4M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SPOK trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SPOK's P/E ratio is 17.75. In terms of profitability, NH's ROE is +0.35%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, NH is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for NH.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
NH vs SY Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SY trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SY's P/E ratio is -5.09. In terms of profitability, NH's ROE is +0.35%, compared to SY's ROE of -0.16%. Regarding short-term risk, NH is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for NH.Check SY's competition here
American Well Corporation (NYSE: AMWL)
NH vs AMWL Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, AMWL has a market cap of 210.1M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while AMWL trades at $12.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas AMWL's P/E ratio is -2.42. In terms of profitability, NH's ROE is +0.35%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, NH is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for NH.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
NH vs HCAT Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, HCAT has a market cap of 159.6M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while HCAT trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas HCAT's P/E ratio is 10.80. In terms of profitability, NH's ROE is +0.35%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, NH is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for NH.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
NH vs CPSI Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas CPSI's P/E ratio is -183.80. In terms of profitability, NH's ROE is +0.35%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, NH is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for NH.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
NH vs OPRX Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, OPRX has a market cap of 122.2M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while OPRX trades at $6.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas OPRX's P/E ratio is 5.97. In terms of profitability, NH's ROE is +0.35%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, NH is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for NH.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
NH vs AUGX Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas AUGX's P/E ratio is -4.99. In terms of profitability, NH's ROE is +0.35%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, NH is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for NH.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
NH vs CCLD Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, CCLD has a market cap of 96.5M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while CCLD trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas CCLD's P/E ratio is 8.41. In terms of profitability, NH's ROE is +0.35%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, NH is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for NH.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
NH vs DH Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, DH has a market cap of 77.4M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while DH trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas DH's P/E ratio is 2.82. In terms of profitability, NH's ROE is +0.35%, compared to DH's ROE of -0.67%. Regarding short-term risk, NH is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for NH.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
NH vs FORA Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas FORA's P/E ratio is -24.11. In terms of profitability, NH's ROE is +0.35%, compared to FORA's ROE of -0.17%. Regarding short-term risk, NH is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for NH.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
NH vs CCLDP Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas CCLDP's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, NH is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for NH.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
NH vs ONMD Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, ONMD has a market cap of 37.3M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while ONMD trades at $0.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas ONMD's P/E ratio is -4.37. In terms of profitability, NH's ROE is +0.35%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, NH is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for NH.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
NH vs SNCE Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SNCE's P/E ratio is -0.27. In terms of profitability, NH's ROE is +0.35%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, NH is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for NH.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
NH vs AKLI Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas AKLI's P/E ratio is -0.71. In terms of profitability, NH's ROE is +0.35%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, NH is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for NH.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
NH vs SHLT Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SHLT's P/E ratio is -3.87. In terms of profitability, NH's ROE is +0.35%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, NH is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for NH.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
NH vs ONMDW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, ONMDW has a market cap of 33.2M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas ONMDW's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, NH is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for NH.Check ONMDW's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
NH vs SHCRW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, NH's ROE is +0.35%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, NH is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for NH.Check SHCRW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
NH vs EUDA Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, EUDA has a market cap of 24.9M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while EUDA trades at $13.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas EUDA's P/E ratio is -25.11. In terms of profitability, NH's ROE is +0.35%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, NH is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for NH.Check EUDA's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
NH vs STRM Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas STRM's P/E ratio is -2.40. In terms of profitability, NH's ROE is +0.35%, compared to STRM's ROE of -0.32%. Regarding short-term risk, NH is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for NH.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
NH vs RNLX Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas RNLX's P/E ratio is -0.33. In terms of profitability, NH's ROE is +0.35%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, NH is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for NH.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
NH vs LIFW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas LIFW's P/E ratio is -0.02. In terms of profitability, NH's ROE is +0.35%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, NH is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for NH.Check LIFW's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
NH vs BEATW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, BEATW has a market cap of 21M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas BEATW's P/E ratio is -0.06. In terms of profitability, NH's ROE is +0.35%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, NH is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for NH.Check BEATW's competition here
Babylon Holdings Limited (NYSE: BBLN)
NH vs BBLN Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas BBLN's P/E ratio is -0.04. In terms of profitability, NH's ROE is +0.35%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, NH is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for NH.Check BBLN's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
NH vs ETAO Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas ETAO's P/E ratio is -0.01. In terms of profitability, NH's ROE is +0.35%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, NH is more volatile compared to ETAO. This indicates higher risk in terms of short-term price fluctuations for NH.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
NH vs BFRG Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, BFRG has a market cap of 7.6M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while BFRG trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas BFRG's P/E ratio is -1.20. In terms of profitability, NH's ROE is +0.35%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, NH is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for NH.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
NH vs HLTH Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while HLTH trades at $25.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas HLTH's P/E ratio is -0.02. In terms of profitability, NH's ROE is +0.35%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, NH is more volatile compared to HLTH. This indicates higher risk in terms of short-term price fluctuations for NH.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
NH vs SCNX Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SCNX has a market cap of 6.3M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SCNX's P/E ratio is -0.16. In terms of profitability, NH's ROE is +0.35%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, NH is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for NH.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
NH vs UPH Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas UPH's P/E ratio is -0.07. In terms of profitability, NH's ROE is +0.35%, compared to UPH's ROE of -1.05%. Regarding short-term risk, NH is more volatile compared to UPH. This indicates higher risk in terms of short-term price fluctuations for NH.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
NH vs UPH-WT Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, NH is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for NH.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
NH vs MGRX Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, MGRX has a market cap of 4.3M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while MGRX trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas MGRX's P/E ratio is -0.31. In terms of profitability, NH's ROE is +0.35%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, NH is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for NH.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
NH vs PEARW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas PEARW's P/E ratio is -0.00. In terms of profitability, NH's ROE is +0.35%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, NH is more volatile compared to PEARW. This indicates higher risk in terms of short-term price fluctuations for NH.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
NH vs PEAR Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas PEAR's P/E ratio is -0.08. In terms of profitability, NH's ROE is +0.35%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, NH is more volatile compared to PEAR. This indicates higher risk in terms of short-term price fluctuations for NH.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
NH vs OTRK Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas OTRK's P/E ratio is -0.02. In terms of profitability, NH's ROE is +0.35%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, NH is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for NH.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
NH vs VSEEW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, NH's ROE is +0.35%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, NH is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for NH.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
NH vs HCTI Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, HCTI has a market cap of 2M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while HCTI trades at $1.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas HCTI's P/E ratio is -0.22. In terms of profitability, NH's ROE is +0.35%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, NH is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for NH.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
NH vs CMAX Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas CMAX's P/E ratio is -0.00. In terms of profitability, NH's ROE is +0.35%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, NH is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for NH.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
NH vs VSEE Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, VSEE has a market cap of 1.5M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while VSEE trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas VSEE's P/E ratio is -0.18. In terms of profitability, NH's ROE is +0.35%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, NH is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for NH.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
NH vs ACON Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, ACON has a market cap of 1.4M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while ACON trades at $2.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas ACON's P/E ratio is -0.24. In terms of profitability, NH's ROE is +0.35%, compared to ACON's ROE of -0.54%. Regarding short-term risk, NH is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for NH.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
NH vs LIFWZ Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, NH is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for NH.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
NH vs EUDAW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, NH's ROE is +0.35%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, NH is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for NH.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
NH vs WORX Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, WORX has a market cap of 594.8K. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while WORX trades at $0.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas WORX's P/E ratio is -0.65. In terms of profitability, NH's ROE is +0.35%, compared to WORX's ROE of -0.65%. Regarding short-term risk, NH is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for NH.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
NH vs MSPRZ Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, NH is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for NH.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
NH vs KERNW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas KERNW's P/E ratio is -0.00. In terms of profitability, NH's ROE is +0.35%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, NH is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for NH.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
NH vs KERN Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas KERN's P/E ratio is -0.01. In terms of profitability, NH's ROE is +0.35%, compared to KERN's ROE of -0.17%. Regarding short-term risk, NH is more volatile compared to KERN. This indicates higher risk in terms of short-term price fluctuations for NH.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
NH vs LIFWW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas LIFWW's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, NH is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for NH.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
NH vs ZCMD Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, ZCMD has a market cap of 51.1K. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while ZCMD trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas ZCMD's P/E ratio is -0.05. In terms of profitability, NH's ROE is +0.35%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, NH is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for NH.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
NH vs CMAXW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas CMAXW's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, NH is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for NH.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
NH vs ACONW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, ACONW has a market cap of 11.7K. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas ACONW's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, NH is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for NH.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBC)
NH vs MTBC Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, MTBC has a market cap of 0. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas MTBC's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, NH is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for NH.Check MTBC's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
NH vs MTBCP Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas MTBCP's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, NH is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for NH.Check MTBCP's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
NH vs SMFRW Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas SMFRW's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to SMFRW's ROE of -0.28%. Regarding short-term risk, NH is more volatile compared to SMFRW. This indicates higher risk in terms of short-term price fluctuations for NH.Check SMFRW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
NH vs MSPRV Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas MSPRV's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to MSPRV's ROE of N/A. Regarding short-term risk, NH is more volatile compared to MSPRV. This indicates higher risk in terms of short-term price fluctuations for NH.Check MSPRV's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
NH vs IMS Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, IMS has a market cap of 0. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas IMS's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to IMS's ROE of +0.27%. Regarding short-term risk, NH is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for NH.Check IMS's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
NH vs KURIU Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, KURIU has a market cap of 0. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas KURIU's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, NH is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for NH.Check KURIU's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
NH vs MTBCO Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas MTBCO's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, NH is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for NH.Check MTBCO's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
NH vs CHNGU Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas CHNGU's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, NH is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for NH.Check CHNGU's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
NH vs AFFX Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, AFFX has a market cap of 0. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas AFFX's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, NH is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for NH.Check AFFX's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
NH vs NAVA Comparison July 2026
NantHealth, Inc. (NASDAQ: NH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, NH stands at 0. In comparison, NAVA has a market cap of 0. Regarding current trading prices, NH is priced at $1.35 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
NH currently has a P/E ratio of -0.12, whereas NAVA's P/E ratio is N/A. In terms of profitability, NH's ROE is +0.35%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, NH is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for NH.Check NAVA's competition here